TRADE NAMED PRODUCTS INGREDIENT CLARIFICATION

OMB Control No: 0920-0135	ICR Reference No: 198806-0920-002
Status: Historical Active	Previous ICR Reference No: 198512-0920-002
Agency/Subagency: HHS/CDC	Agency Tracking No:
Title: TRADE NAMED PRODUCTS INGREDIENT CLARIFICATION
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 10/03/1988
Retrieve Notice of Action (NOA)	Date Received in OIRA: 06/30/1988
Terms of Clearance: We have approved this collection of information for one additional year. No later than eight weeks after this approval, the agency shall submit in writing (1) a comparison of the currently anticipated schedule of completion for the NOES data collection with t schedule anticipated when it was first submitted for PRA review, an explanation of any delays and their impact on the practical utility of these data for NIOSH and for other user agencies, and the steps the agency will take in future data collections to avoid similar delay (2) a more detailed explanation of precisely how the data may be used to "assist in measuring the overall impact of Federal activities in occupational safety and health since the OSH Act" (p. 3 of NIOSH submission), with a discussion of how NIOSH intends to use these data for this purpose and schedules for these activities. Finally, the forms approved under this control number shall contain the disclosure statement required at 5 CFR 1320.21.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	09/30/1989	09/30/1989	09/30/1988
Responses	13,333	0	100,000
Time Burden (Hours)	6,167	0	9,250
Cost Burden (Dollars)	0	0	0

---

Abstract: THIS INFORMATION COLLECTION ACTIVITY IS NECESSARY TO COMPLETE THE NATIONAL OCCUPATIONAL EXPOSURE SURVEY (NOES). THIS DATA BASE IS USED B NIOSH AND OTHERS TO SUGGEST PRIORITIES FOR RESEARCH ACTIVITIES AND TO IDENTIFY OCCUPATIONAL GROUPS WITH A POTENTIAL FOR ELEVATED HEALTH RISK PRODUCT MANUFACTURERS COMPRISE THE RESPONDENT GROUP.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title Form No. Form Name TRADE NAMED PRODUCTS INGREDIENT CLARIFICATION CDC/NIOSH, 2.138

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	13,333	100,000	0	-86,667	0	0
Annual Time Burden (Hours)	6,167	9,250	0	-3,083	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
		(a) It is necessary for the proper performance of agency functions;
		(b) It avoids unnecessary duplication;
		(c) It reduces burden on small entities;
		(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
		(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
		(f) It indicates the retention periods for recordkeeping requirements;
		(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
			(i) Why the information is being collected;
			(ii) Use of information;
			(iii) Burden estimate;
			(iv) Nature of response (voluntary, required for a benefit, or mandatory);
			(v) Nature and extent of confidentiality; and
			(vi) Need to display currently valid OMB control number;
		(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
		(i) It uses effective and efficient statistical survey methodology (if applicable); and
		(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date: 06/30/1988

---